Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: We investigated the effect of inoculum size on MIC, bactericidal activity and the post-antibiotic effect (PAE) of carbapenems (imipenem, panipenem and meropenem) and injectable quinolones (pazufloxacin and ciprofloxacin) against Staphylococcus aureus and Pseudomonas aeruginosa, and also the relationship between in vivo systemic infection by changing the inoculum size injected in mice. RESULTS: Increasing the bacterial inoculum (10(5)-10(8) cfu/mL) had no significant effect on the MIC of any of the tested antimicrobial agents. With the standard inocula (10(6) cfu/mL) of both test strains, all the antimicrobial agents showed bactericidal activity; however, increasing the inoculum size to >10(8) cfu/mL resulted in a reduction in bactericidal activity of all the antimicrobial agents against S. aureus Smith. In contrast, increasing the inoculum size of P. aeruginosa exerted only a minimal influence on the bactericidal activity of fluoroquinolones, but resulted in a reduction in the bactericidal activity of carbapenems. With the standard inoculum size of S. aureus Smith, pre-incubation with fluoroquinolones and carbapenems, except for meropenem, was sufficient to produce PAEs. When the inoculum was increased, the duration of the PAEs of these antimicrobial agents was reduced; however, those of fluoroquinolones were longer than carbapenems. Inoculum size had a greater influence on the in vivo efficacy of carbapenems than that of fluoroquinolones. CONCLUSIONS: Our results suggest that decreased bactericidal activity, or the in vitro PAE of carbapenems and fluoroquinolones, is related to the reduced in vivo protective effect against infection caused by high inoculum with S. aureus or P. aeruginosa.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, fluoroquinolones and aminoglycoside antibiotics are less affected by the size of the inoculum because of their different mechanisms of bactericidal activity. 81,82”
Citations
Cites
File, T. M., Segreti, J., Dunbar, L., Player, R., Kohler, R., Williams, R. R., Kojak, C., & Rubin, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.1965 · Cited by 360
Brook, I. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.361 · Cited by 241
In vitro activity of ciprofloxacin (Bay o 9867)
Fass, R. J. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.4.568 · Cited by 170
Vogelman, B., & Craig, W. A. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/15.suppl_a.37 · Cited by 153
König, C., Simmen, H. P., & Blaser, J. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.227 · Cited by 144
Craig, W. A. (1991) · Clinical Microbiology Newsletter · doi:10.1016/0196-4399(91)90030-y · Cited by 141
Carbapenems in clinical practice: a guide to their use in serious infection
Bradley, J. S., Garau, J., Lode, H., Rolston, K. V., Wilson, S. E., & Quinn, J. P. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00094-6 · Cited by 140
Postantibiotic effect of imipenem on Pseudomonas aeruginosa
Bustamante, C. I., Drusano, G. L., Tatem, B. A., & Standiford, H. C. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.5.678 · Cited by 137
Gerber, A., Brugger, H. P., Feller, C., Stritzko, T., & Stalder, B. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/153.1.90 · Cited by 122
Dosage Schedules of Antimicrobial Agents: A Historical Review
Kunin, C. M. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.1.4 · Cited by 75
Research works printed but not linked: 1
- Bolmstrom, A., Esberg, K., Wiman, A. et al. (1996). Effects of CO2 incubation on MICs of macrolides? In Programs and Abstracts of the Thirty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996, Poster D38, p. 67. American Society for Microbiology, Washington, DC, USA.
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Antimicrobial Activity and Resistance: Influencing Factors
Li, J., Xie, S., Ahmed, S., Wang, F., Gu, Y., Zhang, C., Chai, X., Wu, Y., Cai, J., & Cheng, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00364 · Cited by 266
Meropenem: A Review of its Use in the Treatment of Serious Bacterial Infections
Baldwin, C. M., Lyseng-Williamson, K. A., & Keam, S. J. (2008) · Drugs · doi:10.2165/00003495-200868060-00006 · Cited by 247
Self-assembly of ciprofloxacin and a tripeptide into an antimicrobial nanostructured hydrogel
Marchesan, S., Qu, Y., Waddington, L. J., Easton, C. D., Glattauer, V., Lithgow, T. J., McLean, K. M., Forsythe, J. S., & Hartley, P. G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.096 · Cited by 227
Fernández, P., Lagaron, J. M., & Ocio, M. J. (2008) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2008.06.001 · Cited by 162
Bulitta, J. B., Yang, J. C., Yohonn, L., Ly, N. S., Brown, S. V., D'Hondt, R. E., Jusko, W. J., Forrest, A., & Tsuji, B. T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00881-09 · Cited by 152
Bergen, P. J., Tsuji, B. T., Bulitta, J. B., Forrest, A., Jacob, J., Sidjabat, H. E., Paterson, D. L., Nation, R. L., & Li, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05298-11 · Cited by 128
Bergen, P. J., Forrest, A., Bulitta, J. B., Tsuji, B. T., Sidjabat, H. E., Paterson, D. L., Li, J., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05028-11 · Cited by 128
Smith, K. P., & Kirby, J. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00433-18 · Cited by 128
Inoculum effect of antimicrobial peptides
Loffredo, M. R., Savini, F., Bobone, S., Casciaro, B., Franzyk, H., Mangoni, M. L., & Stella, L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014364118 · Cited by 123
The inoculum effect and band‐pass bacterial response to periodic antibiotic treatment
Tan, C., Smith, R. P., Srimani, J. K., Riccione, K. A., Prasada, S., Kuehn, M. J., & You, L. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.49 · Cited by 113
Qu, Y., Daley, A. J., Istivan, T. S., Garland, S. M., & Deighton, M. A. (2010) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-9-16 · Cited by 100
In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa
Walsh, C. C., McIntosh, M. P., Peleg, A. Y., Kirkpatrick, C. M. J., & Bergen, P. J. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv221 · Cited by 96
Docobo-Pérez, F., López‐Cerero, L., López-Rojas, R., Egea, P., Domínguez-Herrera, J., Rodríguez‐Baño, J., Pascual, Á., & Pachón, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02190-12 · Cited by 74
Kristoffersson, A., David‐Pierson, P., Parrott, N. J., Kuhlmann, O., Lavé, T., Friberg, L. E., & Nielsen, E. I. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1856-x · Cited by 67
Ferran, A. A., Toutain, P., & Bousquet‐mélou, A. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.09.005 · Cited by 60
Mohamed, A. F. S., Kristoffersson, A., Karvanen, M., Nielsen, E. I., Cars, O., & Friberg, L. E. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv488 · Cited by 58
Bouchelaghem, S., Das, S., Naorem, R. S., Czuni, L., Papp, G., & Kocsis, M. (2022) · Molecules · doi:10.3390/molecules27020574 · Cited by 58
Radenkovs, V., Kviesis, J., Juhņeviča-Radenkova, K., Валдовска, А., Püssa, T., Kļaviņš, M., & Drudze, I. (2018) · Plants · doi:10.3390/plants7040090 · Cited by 53
Lee, D., Murakami, Y., Andes, D. R., & Craig, W. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00362-12 · Cited by 51
Kesteman, A.-S., Ferran, A. A., Perrin‐Guyomard, A., Laurentie, M., Sandérs, P., Toutain, P., & Bousquet‐mélou, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00608-09 · Cited by 49
Heffernan, A. J., Lim, S. M. S., Lipman, J., & Roberts, J. A. (2021) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2021.100970 · Cited by 48
Drug detoxification dynamics explain the postantibiotic effect
Srimani, J. K., Huang, S., Lopatkin, A. J., & You, L. (2017) · Molecular Systems Biology · doi:10.15252/msb.20177723 · Cited by 47
Lhermie, G., Ferran, A. A., Assié, S., Cassard, H., Garch, F. E., Schneider, M., Woerhlé, F., Pacalin, D., Delverdier, M. E., Bousquet‐mélou, A., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00237 · Cited by 47
Ferran, A. A., Dupouy, V., Toutain, P., & Bousquet‐mélou, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00156-07 · Cited by 46
Principles of Antimicrobial Therapy: What Should We Be Using?
Southwood, L. L. (2006) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2006.04.004 · Cited by 45
Barton Pai, A., Pai, M. P., Depczynski, J., McQuade, C. R., & Mercier, R.-C. (2006) · American Journal of Nephrology · doi:10.1159/000094343 · Cited by 39
Vasseur, M. V., Laurentie, M., Rolland, J.-G., Perrin‐Guyomard, A., Henri, J., Ferran, A. A., Toutain, P., & Bousquet‐mélou, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02135-13 · Cited by 41
Han, S., Yeo, J., Baek, H.-J., Lin, S.-M., Meyer, S. J., & Molan, P. C. (2009) · Journal of Asian Natural Products Research · doi:10.1080/10286020903164277 · Cited by 39
The Pharmacodynamics of Antimicrobial Agents
Martinez, M. N., Toutain, P., & Turnidge, J. D. (2013) · Wiley eBooks · doi:10.1002/9781118675014.ch5 · Cited by 36
Adler, A., Dalak, M. A. B., Chmelnitsky, I., & Carmeli, Y. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00533-15 · Cited by 36
Maisuria, B. B., Actis, M. L., Hardrict, S. N., Falkinham, J. O., Cole, M. F., Cihlar, R. L., Peters, S. M., Macri, R. V., Sugandhi, E. W., Williams, A. A., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.036 · Cited by 32
Thiagaraj, A. K., Malviya, M., Htun, W. W., Telila, T. A., Lerner, S. A., Elder, M. D., & SCHREIBER, T. L. (2017) · Future Cardiology · doi:10.2217/fca-2016-0076 · Cited by 31
Mitchell, J., McKellar, Q., & McKeever, D. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044158 · Cited by 28
Influence of nanohydroxyapatite surface properties on Staphylococcus epidermidis biofilm formation
Barros, J., Grenho, L., Manuel, C., Ferreira, C., Melo, L. F., Nunes, O. C., Monteiro, F. J., & Ferraz, M. P. (2013) · Journal of Biomaterials Applications · doi:10.1177/0885328213507300 · Cited by 26
Lhermie, G., Toutain, P., Garch, F. E., Bousquet‐mélou, A., & Assié, S. (2017) · Frontiers in Veterinary Science · doi:10.3389/fvets.2017.00143 · Cited by 25
Boyd, M., Santoro, D., & Gram, D. (2019) · Veterinary Dermatology · doi:10.1111/vde.12717 · Cited by 25
Mathematical Modeling To Characterize the Inoculum Effect
Bhagunde, P. R., Chang, K., Singh, R., Singh, V., Garey, K. W., Nikolaou, M., & Tam, V. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01831-09 · Cited by 22
Killing of Escherichia coli by β-lactams at different inocula
Tam, V. H., Ledesma, K. R., Chang, K., Wang, T.-Y., & Quinn, J. P. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.01.018 · Cited by 19
Guo, C., Liao, X., Wang, M., Wang, F., Yan, C., Xiao, X., Sun, J., & Liu, Y. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02065-15 · Cited by 19
Vasseur, M. V., Lacroix, M. Z., Toutain, P., Bousquet‐mélou, A., & Ferran, A. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182863 · Cited by 18
Lhermie, G., Dupouy, V., Garch, F. E., Ravinet, N., Toutain, P., Bousquet‐mélou, A., Seegers, H. H., & Assié, S. (2017) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2016.2176 · Cited by 17
Akrong, G., Chauzy, A., Aranzana‐Climent, V., Lacroix, M., Deroche, L., Prouvensier, L., Buyck, J. M., Couet, W. R., & Marchand, S. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01789-21 · Cited by 16
Chan, E., Zhou, S., Sahasranaman, S., & Duan, W. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9783-x · Cited by 14
Martinez, M. N., Miller, R. A., Martín‐Jiménez, T., & Sharkey, M. (2022) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.13088 · Cited by 12
Soleimani, S., Wu, T., Liu, J., & Danquah, M. K. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07643-7 · Cited by 11
Agyemang, K., Donkor, P. O., Ayim, I., Adzitey, F., Lin, L., & Cui, H. (2020) · Journal of Food Processing and Preservation · doi:10.1111/jfpp.14489 · Cited by 11
RetractedChen, J., San, S. S. S., Kung, A., Tomasek, M., Liu, D., Rodgers, W. H., & Gau, V. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263868 · Cited by 11
Deemter, D., Coelho, F. E. B., Oller, I., Malato, S., & Amat, A. M. (2022) · Catalysts · doi:10.3390/catal12050552 · Cited by 11
PKPD Modeling of the Inoculum Effect of Acinetobacter baumannii on Polymyxin B in vivo
Chauzy, A., Akrong, G., Aranzana‐Climent, V., Moreau, J., Prouvensier, L., Mirfendereski, H., Buyck, J. M., Couet, W. R., & Marchand, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.842921 · Cited by 10
Lhermie, G., Garch, F. E., Toutain, P., Ferran, A. A., & Bousquet‐mélou, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141441 · Cited by 11
Leonard, S. N., Supple, M. E., Gandhi, R. G., & Patel, M. D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02127-12 · Cited by 10
Hindieh, P., Yaghi, J., Khoury, A. E., Chokr, A., Atoui, A., Louka, N., & Assaf, J. C. (2022) · AMB Express · doi:10.1186/s13568-022-01468-w · Cited by 9
The pharmacodynamic inoculum effect from the perspective of bacterial population modelingPreprint
Baeder, D. Y., & Regoes, R. R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/550368 · Cited by 8
Guillot, J.-F., Bastien, J., Bertin, J., Bousquet‐mélou, A., Gicquel-Bruneau, M., Chauvin, C., Faroult, B., Fric, D., Gay, E., Gidenne, T. N., et al. (2014) · HAL · Cited by 8
Şimşek, E., Kim, K., Lu, J. G., Silver, A., Luo, N., Lee, C. T., & You, L. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00046-5 · Cited by 7
Lorenzutti, A. M., Andrés, M. I. S., Fernández-Varón, E., Zarazaga, M. D. P., Molina-López, A. M., & Serrano, J. M. (2021) · Antibiotics · doi:10.3390/antibiotics10111290 · Cited by 6
Microscopic Analysis of Bacterial Inoculum Effect Using Micropatterned Biochip
Hwang, J. H., Lee, S., & Choi, J. (2021) · Antibiotics · doi:10.3390/antibiotics10030300 · Cited by 6
Kaya, Y., Korkmaz, K., Karaaslan, N., Ortakcı, F., Şengül, M., & Dertli, E. (2025) · Journal of Food Safety · doi:10.1111/jfs.70039 · Cited by 5
In Vitro Pharmacodynamics of AZD5206 against Staphylococcus aureus
Tam, V. H., Chang, K., Yang, Z., Newman, J., & Hu, M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01208-12 · Cited by 5
Ngo-Mback, M. N. L., Mback, M. N. L. N., Nguimatsia, F., Kenmogne, S. B., Kouamouo, J., Tchuitio, L. L. N., Melogmo, Y. K. D., & Dongmo, P. M. J. (2021) · Mediterranean Journal of Chemistry · doi:10.13171/mjc02102021555mnlnm · Cited by 4
Modelling Staphylococcus aureus–induced septicemia using NMR
Plummer, R., Bodkin, J. A., Yau, T. W., Power, D., Pantarat, N., Larkin, T. J., Szekely, D., Bubb, W. A., Sorrell, T. C., & Kuchel, P. W. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21392 · Cited by 4
Kesteman, A.-S. (2009) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III) · Cited by 4
Nathalie, L., Alimsardjono, L., & Isnaeni, I. (2019) · JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA · doi:10.20473/jfiki.v6i12019.25-31 · Cited by 3
Strukova, E. N., Абрамович, П. Ю., Golikova, M. V., & Zinner, S. H. (2024) · Pharmaceuticals · doi:10.3390/ph17121683 · Cited by 3
Golikova, M. V., Alieva, K. N., Strukova, E. N., Savelieva, J. R., Kondratieva, D. A., Dovzhenko, S. A., Kobrin, M. B., Андреевич, А. В., Avdeeva, A. A., & Zinner, S. H. (2025) · Antibiotics · doi:10.3390/antibiotics14030258 · Cited by 3
Zhong, L.-G., Tang, S.-J., Liang, L.-Y., Yao, X., Sun, L., Sun, J. G., Liao, X., & Zhou, Y. (2025) · BMC Veterinary Research · doi:10.1186/s12917-025-04974-8 · Cited by 3
Jõers, A., Putrinš, M., Kaldalu, N., Luidalepp, H., & Tenson, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-25241-0_9 · Cited by 2
Nanomaterial-Mediated Delivery of Antimicrobial Agents: ‘The Nanocarriers’
Barathe, P., Reddy, S. M. L., Kaur, K., Shriram, V., Bhagwat, R. V., Dey, A., Verma, S. K., & Kumar, V. (2022) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-10220-2_3 · Cited by 2
Suppressing Resistance Development
Tam, V. H. (2013) · Springer eBooks · doi:10.1007/978-0-387-75613-4_7 · Cited by 2
Molina, F., Agudelo, C. A., Fonseca-Ruiz, N. J., Hidrón, A., Jiménez, C. A., Ochoa, Á., Restrepo, C. A. A., Trompa, I. M., & Roncancio, G. E. (2015) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2015.11.001 · Cited by 2
Ferran, A. A. (2009) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III) · Cited by 2
Biotransformation of Pharmaceuticals by Comamonas and Aeromonas SpeciesPreprint
Sajid, A., & Yahya, S. (2021) · Research Square · doi:10.21203/rs.3.rs-144884/v1 · Cited by 1
Deemter, D. (2024) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/203099 · Cited by 1
Lallemand, E. A. (2017) · theses.fr (ABES) · doi:10.70675/2f650ea9z81dez4d18za583zdc43e75b8437 · Cited by 1
Medu, E. O. (2013) · Open Access Institutional Repository at Robert Gordon University (Robert Gordon University) · Cited by 1
Paraprostaatcyste met urotheliale aflijning bij een hond
Cicchelero, L., Huyghe, S., Chiers, K., Volckaert, V., Melis, S., Paepe, D., Furcas, A., & de Rooster, H. (2012) · Vlaams Diergeneeskundig Tijdschrift · doi:10.21825/vdt.v81i6.18320
of Klebsiella pneumoniae in a rat lung infection model.
Kesteman, A.-S., Ferran, A. A., Laurentie, M., Sandérs, P., Toutain, P., & Bousquet‐mélou, A. (2010)
Optimising use of fosfomycin against multidrug-resistant Pseudomonas aeruginosa
Walsh, C. C. (2017) · Figshare · doi:10.4225/03/58b8bbfe72640
A mechanistic understanding of the postantibiotic effect and treatment strategies
Srimani, J. K. (2017) · DukeSpace (Duke University)
Alieva, K. N., Golikova, M. V., Kondratieva, D. A., & Kuznetsova, A. A. (2024) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2024-69-3-4-42-50
Hindieh, P., Yaghi, J., Khoury, A. E., Chokr, A., Atoui, A., Louka, N., & Assaf, J. C. (2022) · Figshare · doi:10.6084/m9.figshare.21268916
Influence of the Antimicrobial Susceptibility Methods in the Clinical Use of Polymyxins
Silva, I. G. D. S. E. (2010) · Americanae (AECID Library)
Ngotom, J. K., Fliss, I., & Aïder, M. (2026) · Food Research International · doi:10.1016/j.foodres.2026.120604
A stochastic single-cell-based framework for MIC determination
Papagianeli, S. D., Aspridou, Z., & Koutsoumanis, K. P. (2026) · Journal of Applied Microbiology · doi:10.1093/jambio/lxag120
Metadata
- Authors
- Mizunaga, S., Kamiyama, T., Fukuda, Y., Takahata, M., & Mitsuyama, J.
- Corresponding author
- Mizunaga, Shingo
- ORCID
- Takahata, Masahiro
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-12
- Volume
- 56
- Issue
- 1
- Pages
- 91-96
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2162909214
- Semantic Scholar
- 65aaabf2980c730a535b1152de5bf9cb289bc76f
- Cited by
- 78
- References
- 22
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2022: 8 · 2021: 6 · 2020: 1 · 2019: 4 · 2018: 3 · 2017: 8 · 2016: 3 · 2015: 6 · 2014: 2 · 2013: 7 · 2012: 3
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- inoculum size, Staphylococcus aureus, Pseudomonas aeruginosa, fluoroquinolones, carbapenems, imipenem, panipenem, meropenem, pazufloxacin, ciprofloxacin, minimum inhibitory concentration, bactericidal activity, post-antibiotic effect, in vivo efficacy, systemic infection, mice
- MeSH terms
- Animals, Ciprofloxacin, Male, Mice, Inbred ICR, Microbial Sensitivity Tests, Oxazines, Pseudomonas aeruginosa, Pseudomonas Infections, Staphylococcal Infections, Staphylococcus aureus, Carbapenems, Fluoroquinolones, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.